Press Releases
-
PDA Education to Offer FDA CDER Five Specialized Courses on Sterilization and Media Fills
Bethesda, Md., August 12, 2016 – The Parenteral Drug Association (PDA) Education—Where Excellence Begins—announces the development of five specialized courses for officials in the U.S. FDA’s Center for Drug Evaluation and Research, commencing in September and running through early 2017. -
PDA Announces over 25 FDA Officials at Podium for 25th PDA/FDA Joint Regulatory Conference
Bethesda, Md., July 26, 2016 – The Parenteral Drug Association (PDA) proudly announces the appearance of more than 25 U.S. FDA officials as speakers and moderators for the Silver, 25th Anniversary PDA/FDA Joint Regulatory Conference at the Renaissance Washington, DC Downtown Hotel, September 12-14, 2016. -
PDA and PIC/S Offer 2-Day Training on GMPs for Pharma Ingredients in San Juan Aug. 8-9 Regulators from around the world will be on hand at the two-day event
Bethesda, Md., July 21, 2016 – The Parenteral Drug Association (PDA) invites pharmaceutical professionals and regulatory officials to participate in a 2-day, experienced-based training course on the application of good manufacturing practices (GMPs) regulations to active pharmaceutical ingredients (APIs) production in San Juan, Puerto Rico, August 8-9. -
U.S. FDA to Speak on Biosimilars at June PDA/PQRI Conference in Baltimore
Bethesda, Md., June 2, 2016 – The Parenteral Drug Association, Inc. (PDA) announced the participation of four confirmed officials from the U.S. FDA at its Biosimilars Conference, cosponsored with the Product Quality Research Institute, at the Hilton Baltimore, Baltimore, Md., June 20-21. -
PDA Trains Six Auditors from Two Companies in Quality Culture Assessment Tool Pilot
Bethesda, Md., May 19, 2016 – The Parenteral Drug Association (PDA) today launched a pilot for its Quality Culture Assessment Tool with an assessor training session. Members of PDA’s Quality Culture Maturity Task Force met with six auditors from two companies to introduce the assessment tool and learn how to apply it to simulated manufacturing case studies. -
Two PDA Leaders Recognized as Most Influential People in Drug Development and Manufacture in 2016
Bethesda, Md., May 10, 2016 – The Parenteral Drug Association, Inc. (PDA) is pleased to announce that its current volunteer Chair Martin Van Trieste (Amgen) and one of its past chairs, James Agalloco, have been recognized by The Medicine Maker among the “top 100 most influential people in the world of drug development and manufacture.” -
PDA Receives First Johnson & Johnson Kilmer Award for Contributions to Sterility Assurance Science
NEW BRUNSWICK, N.J. (May 6, 2016) – The Parenteral Drug Association, Inc. (PDA) was presented with the Kilmer Award in recognition of the Association’s longstanding leadership in contributing to the science of sterility assurance. -
PDA’s Leadership Challenges Next Generation of Parenteral Manufacturers to be Innovative
San Diego, Ca., April 19, 2016 – The Parenteral Drug Association, Inc. (PDA) opened its two-day workshop on current challenges in aseptic processing with a challenge to the younger attendees to question “why and why not” in regard to the way their companies manufacture sterile drug products. -
PDA Launches Pharmaceutical Manufacturing Data Integrity Webpage
Bethesda, Md., March 11, 2016 – The Parenteral Drug Association (PDA) is rolling out resources for pharmaceutical companies to use for strengthening the integrity of their manufacturing and quality data as part of a comprehensive effort to assist the industry with this sensitive and important area. -
Parenteral Drug Association Publishes First-of-its-Kind Comparison of Sterile Processing GMPs
Bethesda, Md., February 9, 2016 – The Parenteral Drug Association, Inc. (PDA), the leading community for pharmaceutical professionals developing and manufacturing sterile drug products, today announced the publication of Global Sterile Manufacturing Regulatory Guidance Comparison – With link to Comparison Spreadsheet. -
PDA Introduces Newly Elected Executive Committee and Board Members
Bethesda, Md., December 8, 2015 – The Parenteral Drug Association (PDA) announced the results of its Board of Directors election, including newly elected members to the Executive Committee. -
PDA’s Bob Dana to Retire; Craig Elliott to Lead PDA Education starting in 2016
Bethesda, Md., November 18, 2015 – The Parenteral Drug Association (PDA) has announced a change in leadership for its education programs. -
2015 PDA Quality Metrics Conference Offers Latest Details on FDA’s Metrics Gathering Program
Bethesda, Md., November 4, 2015 – The Parenteral Drug Association (PDA) is sponsoring its third conference on quality metrics Nov. 9-11 at the Bethesda North Marriott Hotel and Conference Center. -
103 Vendors Displaying Solutions at 2015 PDA Universe of Pre-filled Syringes Conference
Bethesda, Md., October 27, 2015 – The Parenteral Drug Association (PDA) is once again hosting its Universe of Pre-Filled Syringes and Injection Devices conference in Europe. The November 3-4 event takes place in the Austria Center Vienna. This year, 103 vendors will be on hand to display their products and solutions for pharmaceutical companies looking to offer their products in these devices, which are rapidly becoming standard for injectable products. -
PDA Presents Largest Exhibit of Commercial Inspection Hardware at ’15 Visual Inspection Forum
Bethesda, Md., October 22, 2015 – In addition to the leading forum for visual inspection of parenteral products, the Parenteral Drug Association (PDA) is proud to offer the largest exhibition of commercial visual inspection hardware at the 2015 Visual Inspection Forum in Bethesda, Md., October 26-27. -
PDA’s Annual Global Conference on Pharmaceutical Microbiology Celebrates 10 Years
Bethesda, Md., October 14, 2015 – The Parenteral Drug Association (PDA) is celebrating the tenth anniversary of its Annual Global Conference on Pharmaceutical Microbiology. This annual event brings together microbiologists throughout the industry and regulatory bodies to discuss the latest trends in microbial testing, sterilization technology, and other topics of interest to this scientific community. -
PDA Presents its Perspective on the US FDA Quality Metrics Draft Guidance at Public Meeting
Bethesda, Md., August 24, 2015 – The Parenteral Drug Association (PDA) today presented its perspective on the U.S. FDA’s draft Request for Quality Metrics Guidance for Industry at a public meeting at FDA’s White Oak Campus in Silver Spring, Md. -
PDA and PIC/S Offer ICH Q7 Training in Hyderbad and Ahmedabad India
Bethesda, Md., July 27, 2015 – The Parenteral Drug Association (PDA) is teaming up with the Pharmaceutical Inspection Co-operation Scheme (PIC/S) to conduct training for pharmaceutical professionals in Hyderbad and Ahmedabad India on the International Conference on Harmonisation quality guideline Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. -
Parenteral Drug Association Education approved by N.J. Engineering Board as CPC Provider
Bethesda, Md. June 29, 2015 - The Parenteral Drug Association is pleased to announce that the New Jersey Board of Professional Engineers and Land Surveyors has approved PDA Education as a provider of courses to professional engineers for continuing professional competency (CPC) credits. -
PDA Technical Report No. 69: Bioburden and Biofilm Management in Pharmaceutical Operations
Bethesda, Md., June 10, 2015 – Manufacturers of sterile drug products devote significant resources on programs to control microbial contamination in their products/processes. Bioburden and biofilm management is a significant aspect of microbial control strategies. Persistent bioburden and biofilm problems have been directly linked to several recalls and plant shutdowns.